Notably, D-CuP exhibited faster cell migration than M-CuP
Intriguingly, SPR indicated that these peptides displayed lower binding affinities and had reduced competitive inhibition of FAT-LD2 binding
Unlike drugs such as phentermine, Cagrilintide is a non-stimulant peptide
Brunger, a Howard Hughes Medical Institute investigator, shares senior authorship of the study with Burton Dickey, MD, a professor of pulmonary medicine at the MD Anderson Cancer Center in Houston, and Manfred Frick, PhD, a professor of medicine at Ulm University in Germany
More in my new Substack: To view or add a comment, sign in Hope for Millions: A Potential Cure for Diabetes In a groundbreaking medical breakthrough, a 42-year-old man with Type 1 diabetes has regained the ability to produce his own insulin, thanks to donor islet cells edited with CRISPR-Cas12b
Always patch-test new formulations